1. Sargent S. The treatment of depressive states. Int J Neurol. 1967;6:53–64. [PubMed] [Google Scholar]
2. Agras WS, Chapin HN, Oliveau DC. The natural history of phobia. Arch Gen Psychiatry. 1972;26:315–317. [PubMed] [Google Scholar]
3. Marks IM. New approaches to the treatment of obsessive-compulsive disorders. J Nerv Ment Dis. 1973;156:420–426. [PubMed] [Google Scholar]
4. Waskow IE. Specification of the technique variable in the NIMH Treatment of Depression Collaborative Research Program. In: Williams JBW, Spitzer RL, editors. Psychotherapy Research: Where Are We and Where Should We Go? New York: Guilford; 1984. pp. 150–159. [Google Scholar]
5. Docherty JP. Implications of the technological model of psychotherapy. Ibid. :139–149. [Google Scholar]
6. Elkin I, Pilkonis PA, Docherty JP, Sotsky SM. Conceptual and methodologic issues in comparative studies of psychotherapy and pharmacotherapy, I: active ingredients and mechanisms of change. Am J Psychiatry. 1988;145:909–917. [PubMed] [Google Scholar]
7. Elkin I, Pilkonis PA, Docherty JP, Sotsky SM. Conceptual and methodological issues in comparative studies of psychotherapy and pharmacotherapy, II: nature and timing of treatment effects. Am J Psychiatry. 1988;145:1070–1076. [PubMed] [Google Scholar]
8. Woody GE, Luborsky L, McLellan AT, O’Brien CP, Beck AT, Blaine JD, Herman L, Hole A. Psychotherapy for opiate addicts: does it help? Arch Gen Psychiatry. 1983;40:639–645. [PubMed] [Google Scholar]
9. Onken LS, Blaine JD. Psychotherapy and counseling research in drug abuse treatment: questions, problems, and solutions. NIDA Research Monogr. 1990;104:1–8. [PubMed] [Google Scholar]
10. Kang SY, Kleinman PH, Woody GE, Millman RB, Todd TC, Kemp J, Lipton DS. Outcomes for cocaine abusers after once-a-week psychosocial therapy. Am J Psychiatry. 1991;148:630–635. [PubMed] [Google Scholar]
11. Kleber HD, Gawin FH. Cocaine abuse: a review of current and experimental treatments. In: Grabowski J, editor. Cocaine: Pharmacology, Effects and Treatment of Abuse. DHHS Publication (ADM) 84-1326. Rockville, Md: National Institute on Drug Abuse; 1984. pp. 111–129. [PubMed] [Google Scholar]
12. Onken LS, Blaine JD, Battjes R. Behavioral therapy research: a conceptualization of a process. In: Henggeler SW, Santos AB, editors. Innovative Approaches for Difficult-to-Treat Populations. Washington, DC: American Psychiatric Press; 1996. pp. 477–485. [Google Scholar]
13. Rounsaville BJ, Carroll KM, Onken LS. A stage model of behavioral therapies research: getting started and moving on from Stage I. Clin Psychol Sci Pract. 2001;8:133–142. [Google Scholar]
14. Kazdin AE. Comparative outcome studies in psychotherapy: methodological issues and strategies. J Consult Clin Psychol. 1986;54:95–105. [PubMed] [Google Scholar]
15. Carroll KM, Rounsaville BJ. Bridging the gap between research and practice in substance abuse treatment: a hybrid model linking efficacy and effectiveness research. Psychiatr Serv. 2003;54:333–339. [PMC free article] [PubMed] [Google Scholar]
16. Stitzer ML, Bickel WK, Bigelow GE, Liebson IA. Effect of methadone dose contingencies on urinalysis test results of polydrug abusing methadone maintenance patients. Drug Alcohol Depend. 1986;18:341–348. [PubMed] [Google Scholar]
17. Stitzer ML, Iguchi MY, Felch LJ. Contingent take-home incentives: effects on drug use of methadone maintenance patients. J Consult Clin Psychol. 1992;60:927–934. [PubMed] [Google Scholar]
18. Dolan MP, Black JL, Penk WE, Rabinowitz R, DeFord HA. Contracting for treatment termination to reduce illicit drug use among methadone maintenance treatment failures. J Consult Clin Psychol. 1985;53:549–551. [PubMed] [Google Scholar]
19. Kidorf M, Stitzer ML. Contingent use of take-homes and splitdosing to reduce illicit drug use of methadone patients. Behav Ther. 1996;27:41–51. [Google Scholar]
20. Iguchi MY, Stitzer ML, Bigelow GE, Liebson IA. Contingency management in methadone maintenance: effects of reinforcing and aversive consequences on illicit polydrug use. Drug Alcohol Depend. 1988;22:1–7. [PubMed] [Google Scholar]
21. Stitzer ML, Iguchi MY, Kidorf M, Bigelow GE. Contingency management in methadone treatment: the case for positive incentives. In: Onken LS, Blaine JD, Boren JJ, editors. Behavioral Treatments for Drug Abuse and Dependence. Rockville, Md: National Institute on Drug Abuse; 1993. pp. 19–36. [PubMed] [Google Scholar]
22. Budney AJ, Higgins ST, Mercer DE, Carpenter G. NIH Publication 98-4309. Rockville, Md: National Institute on Drug Abuse; 1998. A Community Reinforcement Plus Vouchers Approach: Treating Cocaine Addiction. [Google Scholar]
23. Higgins ST, Wong CJ, Badger GJ, Ogden DE, Dantona RL. Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up. J Consult Clin Psychol. 2000;68:64–72. [PubMed] [Google Scholar]
24. Higgins ST, Badger GJ, Budney AJ. Initial abstinence and success in achieving longer term cocaine abstinence. Exp Clin Psychopharmacol. 2000;8:377–386. [PubMed] [Google Scholar]
25. Higgins ST, Sigmon SC, Wong CJ, Heil SH, Badger GJ, Donham R, Dantona RL, Anthony S. Community reinforcement therapy for cocaine-dependent outpatients. Arch Gen Psychiatry. 2003;60:1043–1052. [PubMed] [Google Scholar]
26. Bickel WK, Amass L, Higgins ST, Badger GJ, Esch RA. Effects of adding behavioral treatment to opioid detoxification with buprenorphine. J Consult Clin Psychol. 1997;65:803–810. [PubMed] [Google Scholar]
27. Shoptaw S, Rotheram-Fuller E, Yang X, Frosch D, Nahom D, Jarvik ME, Rawson RA, Ling W. Smoking cessation in methadone maintenance. Addiction. 2002;97:1317–1328. [PubMed] [Google Scholar]
28. Budney AJ, Higgins ST, Radonovich KJ, Novy PL. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychol. 2000;68:1051–1061. [PubMed] [Google Scholar]
29. Preston KL, Silverman K, Umbricht A, DeJesus A, Montoya ID, Schuster CR. Improvement in naltrexone treatment compliance with contingency management. Drug Alcohol Depend. 1999;54:127–135. [PubMed] [Google Scholar]
30. Carroll KM, Ball SA, Nich C, O’Connor PG, Eagan D, Frankforter TL, Triffleman EG, Shi J, Rounsaville BJ. Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement. Arch Gen Psychiatry. 2001;58:755–761. [PMC free article] [PubMed] [Google Scholar]
31. Carroll KM, Sinha R, Nich C, Babuscio T, Rounsaville BJ. Contingency management to enhance naltrexone treatment of opioid dependence: a randomized clinical trial of reinforcement magnitude. Exp Clin Psychopharmacol. 2002;10:54–63. [PubMed] [Google Scholar]
32. Iguchi MY, Belding MA, Morral AR, Lamb RJ, Husband SD. Reinforcing operants other than abstinence in drug abuse treatment: an effective alternative for reducing drug use. J Consult Clin Psychol. 1997;65:421–428. [PubMed] [Google Scholar]
33. Silverman K, Higgins ST, Brooner RK, Montoya ID, Cone EJ, Schuster CR, Preston KL. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy. Arch Gen Psychiatry. 1996;53:409–415. [PubMed] [Google Scholar]
34. Silverman K, Wong CJ, Umbricht-Schneiter A, Montoya ID, Schuster CR, Preston KL. Broad beneficial effects of cocaine abstinence reinforcement among methadone patients. J Consult Clin Psychol. 1998;66:811–824. [PubMed] [Google Scholar]
35. Silverman K, Wong CJ, Higgins ST, Brooner RK, Montoya ID, Contoreggi C, Umbricht-Schneiter A, Schuster CR, Preston KL. Increasing opiate abstinence through voucher-based reinforcement therapy. Drug Alcohol Depend. 1996;41:157–165. [PubMed] [Google Scholar]
36. Silverman K, Svikis DS, Robles E, Stitzer ML, Bigelow GE. A reinforcement-based therapeutic workplace for the treatment of drug abuse: six-month abstinence outcomes. Exp Clin Psychopharmacol. 2001;9:14–23. [PubMed] [Google Scholar]
37. Silverman K, Svikis DS, Wong CJ, Hampton J, Stitzer ML, Bigelow GE. A reinforcement-based therapeutic workplace for the treatment of drug abuse: three-year abstinence outcomes. Exp Clin Psychopharmacol. 2002;10:228–240. [PubMed] [Google Scholar]
38. Petry NM, Martin B, Cooney JL, Kranzler HR. Give them prizes and they will come: contingency management treatment of alcohol dependence. J Consult Clin Psychol. 2000;68:250–257. [PubMed] [Google Scholar]
39. Petry NM, Martin B. Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients. J Consult Clin Psychol. 2002;70:398–405. [PubMed] [Google Scholar]
40. Petry NM, Tedford J, Austin M, Nich C, Carroll KM, Rounsaville BJ. Prize reinforcement contingency management for treating cocaine abusers: how low can we go, and with whom? Addiction. 2004;99:349–360. [PMC free article] [PubMed] [Google Scholar]
41. Crowley TJ. Research on contingency management treatment of drug dependence: clinical implications and future directions. In: Higgins ST, Silverman K, editors. Motivating Behavior Change Among Illicit Drug Abusers. Washington, DC: American Psychological Association; 1999. pp. 345–370. [Google Scholar]
42. Carroll KM. NIH Publication 98-4308. Rockville, Md: National Institute on Drug Abuse; 1998. A Cognitive-Behavioral Approach: Treating Cocaine Addiction. [Google Scholar]
43. Marlatt GA, Gordon JR. Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. New York: Guilford; 1985. [Google Scholar]
44. Miller WR, Wilbourne PL. Mesa Grande: a methodological analysis of clinical trials of treatments for alcohol use disorders. Addiction. 2002;97:265–277. [PubMed] [Google Scholar]
45. Miller WR, Brown JM, Simpson TL, Handmaker NS, Bien TH, Luckie LF, Montgomery HA, Hester RK, Tonigan JS. What works? a methodological analysis of the alcohol treatment literature. In: Hester RK, Miller WR, editors. Handbook of Alcoholism Treatment Approaches: Effective Alternatives. Boston: Allyn & Bacon; 1995. pp. 12–44. [Google Scholar]
46. DeRubeis RJ, Crits-Christoph P. Empirically supported individual and group psychological treatments for adult mental disorders. J Consult Clin Psychol. 1998;66:37–52. [PubMed] [Google Scholar]
47. Irvin JE, Bowers CA, Dunn ME, Wong MC. Efficacy of relapse prevention: a meta-analytic review. J Consult Clin Psychol. 1999;67:563–570. [PubMed] [Google Scholar]
48. Maude-Griffin PM, Hohenstein JM, Humfleet GL, Reilly PM, Tusel DJ, Hall SM. Superior efficacy of cognitive-behavioral therapy for crack cocaine abusers: main and matching effects. J Consult Clin Psychol. 1998;66:832–837. [PubMed] [Google Scholar]
49. Rohsenow DJ, Monti PM, Martin RA, Michalec E, Abrams DB. Brief coping skills treatment for cocaine abuse: 12-month substance use outcomes. J Consult Clin Psychol. 2000;68:515–520. [PubMed] [Google Scholar]
50. Monti PM, Rohsenow DJ, Michalec E, Martin RA, Abrams DB. Brief coping skills treatment for cocaine abuse: substance abuse outcomes at three months. Addiction. 1997;92:1717–1728. [PubMed] [Google Scholar]
51. McKay JR, Alterman AI, Cacciola JS, Rutherford MJ, O’Brien CP, Koppenhaver J. Group counseling versus individualized relapse prevention aftercare following intensive outpatient treatment for cocaine dependence. J Consult Clin Psychol. 1997;65:778–788. [PubMed] [Google Scholar]
52. Carroll KM, Rounsaville BJ, Gordon LT, Nich C, Jatlow PM, Bisighini RM, Gawin FH. Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch Gen Psychiatry. 1994;51:177–197. [PubMed] [Google Scholar]
53. Carroll KM, Rounsaville BJ, Gawin FH. A comparative trial of psychotherapies for ambulatory cocaine abusers: relapse prevention and interpersonal psychotherapy. Am J Drug Alcohol Abuse. 1991;17:229–247. [PubMed] [Google Scholar]
54. Rosenblum A, Magura S, Palij M, Foote J, Handlesman L, Stimmel B. Enhanced treatment outcomes for cocaine-using methadone patients. Drug Alcohol Depend. 1999;54:207–218. [PubMed] [Google Scholar]
55. Carroll KM, Nich C, Ball SA, McCance-Katz E, Rounsaville BJ. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction. 1998;93:713–728. [PubMed] [Google Scholar]
56. Carroll KM, Fenton LR, Ball SA, Nich C, Frankforter TL, Shi J, Rounsaville BJ. Efficacy of disulfiram and cognitive-behavioral therapy in cocaine-dependent outpatients: a randomized placebo controlled trial. Arch Gen Psychiatry. 2004;64:264–272. [PMC free article] [PubMed] [Google Scholar]
57. Carroll KM, Rounsaville BJ, Nich C, Gordon LT, Wirtz PW, Gawin FH. One year follow-up of psychotherapy and pharmacotherapy for cocaine dependence: delayed emergence of psychotherapy effects. Arch Gen Psychiatry. 1994;51:989–997. [PubMed] [Google Scholar]
58. Carroll KM, Nich C, Ball SA, McCance-Katz EF, Frankforter TF, Rounsaville BJ. One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol abusers: sustained effects of treatment. Addiction. 2000;95:1335–1349. [PubMed] [Google Scholar]
59. Barlow DH. Cognitive behavioral therapy for panic disorder: current status. J Clin Psychiatry. 1997;58(suppl 2):32–36. [PubMed] [Google Scholar]
60. Hollon SD, Shelton RC, Davis DD. Cognitive therapy for depression: conceptual issues and clinical efficacy. J Consult Clin Psychol. 1993;61:270–275. [PubMed] [Google Scholar]
61. Rawson RA, Huber A, McCann MJ, Shoptaw S, Farabee D, Reiber C, Ling W. A comparison of contingency management and cognitive- behavioral approaches during methadone maintenance for cocaine dependence. Arch Gen Psychiatry. 2002;59:817–824. [PubMed] [Google Scholar]
62. Epstein DE, Hawkins WE, Covi L, Umbricht A, Preston KL. Cognitive behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up. Psychol Addict Behav. 2003;17:73–82. [PMC free article] [PubMed] [Google Scholar]
63. Otto MW, Pollack MH, Sachs GS, Reiter SR, Maltzer-Brody S, Rosenbaum JF. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. Am J Psychiatry. 1993;150:1485–1490. [PubMed] [Google Scholar]
64. Spiegel DA, Bruce TJ, Gregg SF, Nuzzarello A. Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder? Am J Psychiatry. 1994;151:876–881. [PubMed] [Google Scholar]
65. Rawson RA, Marinelli Casey PJ, Anglin MD, Dickow A, Frazier Y, Gallagher C, Galloway GP, Herrell J, Huber A, McCann MJ, Obert J, Pennell S, Reiber C, Vandersloot D, Zweben J Methamphetamine Treatment Project Corporate Authors. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence. Addiction. 2004;99:708–717. [PubMed] [Google Scholar]
66. Miller WR, Rollnick S. Motivational Interviewing: Preparing People for Change. 2. New York: Guilford; 2002. [Google Scholar]
67. MTP Research Group. Brief treatments for cannabis dependence: findings from a randomized multisite trial. J Consult Clin Psychol. 2004;72:455–466. [PubMed] [Google Scholar]
68. Dunn C, Deroo I, Rivara FP. The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction. 2001;96:1725–1742. [PubMed] [Google Scholar]
69. Burke BL, Arkowitz H, Menchola M. The efficacy of motivational interviewing: a meta-analysis of controlled clinical trials. J Consult Clin Psychol. 2003;71:843–861. [PubMed] [Google Scholar]
70. Project MATCH Research Group. Matching alcohol treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol. 1997;58:7–29. [PubMed] [Google Scholar]
71. Stephens R, Roffman RA, Curtin L. Comparison of extended versus brief treatments for marijuana use. J Consult Clin Psychol. 2000;68:898–908. [PubMed] [Google Scholar]
72. Carey MP, Maisto SA, Kalichman SC, Forsythe AD, Wright EM, Johnson BT. Enhancing motivation to reduce the risk of HIV infection for economically disadvantaged urban women. J Consult Clin Psychol. 1997;65:531–541. [PMC free article] [PubMed] [Google Scholar]
73. Carey MP, Braaten LS, Maisto SA, Gleason JR, Forsythe AD, Durant LE, Jaworski BC. Using information, motivational enhancement, and skills training to reduce the risk of HIV infection for low-income urban women: a second randomized clinical trial. Health Psychol. 2000;19:3–11. [PubMed] [Google Scholar]
74. Miller WR, Yahne CE, Tonigan JS. Motivational interviewing in drug abuse services: a randomized trial. J Consult Clin Psychol. 2003;71:754–763. [PubMed] [Google Scholar]
75. Donovan DM, Rosengren DB, Downey L, Cox GC, Sloan KL. Attrition prevention with individuals awaiting publicly funded drug treatment. Addiction. 2001;96:1149–1160. [PubMed] [Google Scholar]
76. Booth RE, Kwiatkowski C, Iguchi MY, Pinto F, John D. Facilitating treatment entry among out-of-treatment injection drug users. Public Health Rep. 1998;113(suppl 1):116–128. [PMC free article] [PubMed] [Google Scholar]
77. Baker A, Lewin T, Reichler H, Clancy R, Carr V, Garret R, Sly K, Devir H, Terry M. Motivational interviewing among psychiatric inpatients with substance use disorders. Acta Psychiatr Scand. 2002;106:233–240. [PubMed] [Google Scholar]
78. Henggeler SW, Pickrel SG, Brondino MJ, Crouch JL. Eliminating (almost) treatment dropout of substance abusing or dependent delinquents through home-based multisystemic therapy. Am J Psychiatry. 1996;153:427–428. [PubMed] [Google Scholar]
79. Liddle HA, Dakof GA, Parker K, Diamond GS, Barrett K, Tejeda M. Multidimensional family therapy for adolescent drug abuse: results of a randomized clinical trial. Am J Drug Alcohol Abuse. 2001;27:651–688. [PubMed] [Google Scholar]
80. Stanton MD, Shadish WR. Outcome, attrition, and family-couples treatment for drug abuse: a meta-analysis and review of the controlled, comparative studies. Psychol Bull. 1997;122:170–191. [PubMed] [Google Scholar]
81. Liddle HA, Dakof G. Efficacy of family therapy for drug abuse: promising but not definitive. J Marital Fam Ther. 1995;21:511–543. [Google Scholar]
82. Waldron HB. Adolescent substance abuse and family therapy outcome: a review of randomized trials. Adv Clin Child Psychol. 1997;19:199–234. [Google Scholar]
83. Deas D, Thomas SE. An overview of controlled studies of adolescent substance abuse treatment. Am J Addict. 2001;10:178–189. [PubMed] [Google Scholar]
84. Waldron HB, Slesnick N, Brody JL, Turner CW, Peterson TR. Treatment outcomes for adolescent substance abuse at 4- and 7-month assessments. J Consult Clin Psychol. 2001;69:802–813. [PubMed] [Google Scholar]
85. Fals-Stewart W, O’Farrell TJ, Birchler GR. Behavioral couples therapy for male substance-abusing patients: a cost outcomes analysis. J Consult Clin Psychol. 1997;65:789–802. [PubMed] [Google Scholar]
86. Fals-Stewart W, O’Farrell TJ, Birchler GR. Behavioral couples therapy for male methadone patients: effects on drug-using behavior and relationship adjustment. Behav Ther. 2001;32:391–411. [Google Scholar]
87. Fals-Stewart W, O’Farrell TJ. Behavioral family counseling and naltrexone for male opioid-dependent patients. J Consult Clin Psychol. 2003;71:432–442. [PubMed] [Google Scholar]
88. Kelley ML, Fals-Stewart W. Couples- versus individual-based therapy for alcohol and drug abuse: effects on children’s psychosocial functioning. J Consult Clin Psychol. 2002;70:417–427. [PubMed] [Google Scholar]
89. Azrin NH, Donohue B, Besalel VA, Kogan ES, Acierno R. Youth drug abuse treatment: a controlled outcome study. J Child Adolesc Subst Abuse. 1994;3:1–16. [Google Scholar]
90. Henggeler SW, Borduin CM. Family Therapy and Beyond: A Multisystemic Approach to Treating the Behavior Problems of Children and Adolescents. Pacific Grove, Calif: Brooks/Cole; 1990. [Google Scholar]
91. Henggeler SW, Melton GB, Smith LA. Family preservation using multisystemic therapy: an effective alternative to incarcerating serious juvenile offenders. J Consult Clin Psychol. 1992;60:953–961. [PubMed] [Google Scholar]
92. Borduin CM, Mann BJ, Cone LT, Henggeler SW, Fucci BR, Blaske DM, Williams RA. Multisystemic treatment of serious juvenile offenders: long-term prevention of criminality and violence. J Consult Clin Psychol. 1995;63:569–578. [PubMed] [Google Scholar]
93. Huey SJ, Henggeler SW, Brondino MJ, Pickrel SG. Mechanisms of change in multisystemic therapy: reducing delinquent behavior through therapist adherence and improved family and peer functioning. J Consult Clin Psychol. 2000;68:451–467. [PubMed] [Google Scholar]
94. Henggeler SW, Clingempeel WG, Brondino MJ, Pickrel SG. Four-year follow-up of multisystemic therapy with substance-abusing and substance-dependent juvenile offenders. J Am Acad Child Adolesc Psychiatry. 2002;41:868–874. [PubMed] [Google Scholar]
95. Szapocznik J, Hervis O, Schwartz S. NIH Publication 03-4751. Bethesda, Md: National Institute on Drug Abuse; 2003. Brief Strategic Family Therapy for Adolescent Drug Abuse. [Google Scholar]
96. Szapocznik J, Perez-Vidal A, Brickman AL, Foote FH, Santisteban DA, Hervis O, Kurtines WM. Engaging adolescent drug abusers and their families in treatment: a strategic structural systems approach. J Consult Clin Psychol. 1988;56:552–557. [PubMed] [Google Scholar]
97. Santisteban DA, Coatsworth JD, Perez-Vidal A, Mitrani V, Jean-Gilles M, Szapocznik J. Engaging behavior problem/drug abusing youth and their families in treatment: a replication and further exploration of the factors that contribute to differential effectiveness. J Fam Psychol. 1996;10:35–44. [Google Scholar]
98. Coatsworth JD, Santisteban DA, McBride CK, Szapocznik J. Brief strategic family therapy versus community control: engagement, retention, and an exploration of the moderating role of adolescent severity. Fam Process. 2001;40:313–332. [PubMed] [Google Scholar]
99. Szapocznik J, Kurtines WM, Foote FH, Perez-Vidal A, Hervis O. Conjoint versus one-person family therapy: some evidence for the effectiveness of conducting family therapy through one person. J Consult Clin Psychol. 1986;54:395–397. [PubMed] [Google Scholar]
100. Crits-Christoph P, Siqueland L, Blaine JD, Frank A, Luborsky L, Onken LS, Muenz L, Thase ME, Weiss RD, Gastfriend DR, Woody G, Barber JP, Butler S, Dale D, Salloum I, Bishop S, Najavits L, Lis J. Psychosocial treatments for cocaine dependence: results of the National Institute on Drug Abuse Collaborative Cocaine Study. Arch Gen Psychiatry. 1999;56:495–502. [PubMed] [Google Scholar]
101. Mercer DE, Woody GE. NIH Publication 99-4380. Rockville, Md: National Institute on Drug Abuse; 1999. An Individual Drug Counseling Approach to Treat Cocaine Addiction: The Collaborative Cocaine Treatment Study Model. [Google Scholar]
102. Woody GE, Gallop R, Luborsky L, Blaine JD, Frank A, Salloum IM, Gastfriend DR, Crits-Christoph P Cocaine Psychotherapy Study Group. HIV risk reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study. J Acquir Immune Defic Syndr. 2003;33:82–87. [PubMed] [Google Scholar]
103. Sorensen JL, Copeland AL. Drug abuse treatment as an HIV prevention strategy: a review. Drug Alcohol Depend. 2000;59:17–31. [PubMed] [Google Scholar]
104. Margolin A, Avants SK, Warburton LA, Hawkins KA, Shi J. A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users. Health Psychol. 2003;22:223–228. [PubMed] [Google Scholar]
105. Avants SK, Margolin A, Usubiaga MH, Doebrick C. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of harm reduction group therapy. J Subst Abuse Treat. 2004;26:67–78. [PubMed] [Google Scholar]
